Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-73.89M	-47.83M	-22.71M	-18.16M
Depreciation & Amortization	2.16M	623K	447K	379K
Stock-Based Compensation	11.16M	3.78M	1.02M	229K
Other Working Capital	-567K	992K	1.51M	-406K
Other Non-Cash Items	-1.38M	735K	317K	10K
Deferred Income Tax	n/a	394K	95K	-38K
Change in Working Capital	1.1M	2.31M	1.61M	-85K
Operating Cash Flow	-60.86M	-39.99M	-19.21M	-17.66M
Capital Expenditures	-3.04M	-2.44M	-1.29M	-562K
Cash Acquisitions	-58.71K	93.95K	n/a	n/a
Purchase of Investments	-191.58M	-275.88M	-158.24M	n/a
Sales Maturities Of Investments	250.29M	181.93M	26.22M	n/a
Other Investing Acitivies	58.71K	-93.95K	-1K	n/a
Investing Cash Flow	55.67M	-96.39M	-133.3M	-562K
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	242K	137.4M	131.12M	36.2M
Financial Cash Flow	242.00	137.4K	131.12M	36.2M
Net Cash Flow	-4.94M	1.02M	-21.39M	17.98M
Free Cash Flow	-63.9M	-42.42M	-20.5M	-18.22M